Thomas Ullrich

1.4k total citations
35 papers, 1.1k citations indexed

About

Thomas Ullrich is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Thomas Ullrich has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 9 papers in Organic Chemistry. Recurrent topics in Thomas Ullrich's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Psychedelics and Drug Studies (5 papers) and Neuropeptides and Animal Physiology (5 papers). Thomas Ullrich is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Psychedelics and Drug Studies (5 papers) and Neuropeptides and Animal Physiology (5 papers). Thomas Ullrich collaborates with scholars based in United States, Austria and Switzerland. Thomas Ullrich's co-authors include Kenner C. Rice, James H. Woods, William E. Fantegrossi, Peter Nußbaumer, Gail Winger, Michael Ghobrial, Christine Gräf, Christopher Bishop, Paul D. Walker and Frédéric Bornancin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Thomas Ullrich

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Ullrich United States	18	400	357	219	200	160	35	1.1k
Heng Xu United States	26	1.2k 3.1×	1.2k 3.3×	74 0.3×	128 0.6×	186 1.2×	91	2.0k
Esther Y. Maier United States	16	238 0.6×	177 0.5×	52 0.2×	38 0.2×	39 0.2×	34	858
Jukka Leppänen Finland	16	57 0.1×	263 0.7×	55 0.3×	19 0.1×	110 0.7×	27	897
Hideaki Kobayashi Japan	19	457 1.1×	577 1.6×	28 0.1×	29 0.1×	50 0.3×	77	1.5k
Norihiro Harada Japan	30	830 2.1×	959 2.7×	16 0.1×	25 0.1×	80 0.5×	79	2.5k
Therese Montgomery Ireland	10	220 0.6×	190 0.5×	39 0.2×	61 0.3×	23 0.1×	15	515
Ewa Kędzierska Poland	18	319 0.8×	509 1.4×	23 0.1×	41 0.2×	377 2.4×	69	2.6k
Henar Vázquez‐Villa Spain	19	244 0.6×	410 1.1×	19 0.1×	21 0.1×	871 5.4×	35	1.6k
Justin Grant Canada	13	62 0.2×	130 0.4×	150 0.7×	17 0.1×	224 1.4×	18	938

Countries citing papers authored by Thomas Ullrich

Since Specialization

Citations

This map shows the geographic impact of Thomas Ullrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ullrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ullrich more than expected).

Fields of papers citing papers by Thomas Ullrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ullrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ullrich. The network helps show where Thomas Ullrich may publish in the future.

Co-authorship network of co-authors of Thomas Ullrich

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ullrich. A scholar is included among the top collaborators of Thomas Ullrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ullrich. Thomas Ullrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ullrich, Thomas, Luca Arista, Sven Weiler, et al.. (2022). Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva. Bioorganic & Medicinal Chemistry Letters. 64. 128667–128667. 5 indexed citations

Nkanga, Christian Isalomboto, Andreas Fisch, Mazda Rad‐Malekshahi, et al.. (2020). Clinically established biodegradable long acting injectables: An industry perspective. Advanced Drug Delivery Reviews. 167. 19–46. 115 indexed citations

Ullrich, Thomas, Roland Kern, & Martin Egelhaaf. (2014). Texture-defined objects influence responses of blowfly motion-sensitive neurons under natural dynamical conditions. Frontiers in Integrative Neuroscience. 8. 34–34. 1 indexed citations

Ullrich, Thomas, Roland Kern, & Martin Egelhaaf. (2014). Influence of environmental information in natural scenes and the effects of motion adaptation on a fly motion-sensitive neuron during simulated flight. Biology Open. 4(1). 13–21. 11 indexed citations

Ullrich, Thomas, Dirk Wesenberg, Gerd‐Joachim Krauss, et al.. (2010). Chiral separation of the β₂‐sympathomimetic fenoterol by HPLC and capillary zone electrophoresis for pharmacokinetic studies. Biomedical Chromatography. 24(10). 1125–1129. 9 indexed citations

Davis, Catherine M., Glenn W. Stevenson, Fernando Cañadas, et al.. (2008). Discriminative stimulus properties of naloxone in Long–Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning. Psychopharmacology. 203(2). 421–429. 13 indexed citations

Ullrich, Thomas, Michael Ghobrial, Carsten Peters, et al.. (2007). Synthesis and Immobilization of erythro‐C14‐ω‐Aminosphingosine‐1‐phosphate as a Potential Tool for Affinity Chromatography. ChemMedChem. 3(2). 356–360. 6 indexed citations

Nußbaumer, Peter, Valentı́n Hornillos, Michael Ghobrial, & Thomas Ullrich. (2007). An efficient, one-pot synthesis of various ceramide 1-phosphates from sphingosine 1-phosphate. Chemistry and Physics of Lipids. 151(2). 125–128. 3 indexed citations

Gräf, Christine, et al.. (2007). Regulation and Traffic of Ceramide 1-Phosphate Produced by Ceramide Kinase. Journal of Biological Chemistry. 283(13). 8517–8526. 97 indexed citations

10.

Taylor, Jennifer L., Christopher Bishop, Thomas Ullrich, Kenner C. Rice, & Paul D. Walker. (2006). Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not l-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat. Neuropharmacology. 50(6). 761–768. 38 indexed citations

11.

Winter, J.C., M.D. Zimmerman, Chad J. Reissig, et al.. (2005). The stimulus properties of LSD in C57BL/6 mice. Pharmacology Biochemistry and Behavior. 81(4). 830–837. 19 indexed citations

12.

Herin, David V., Shijing Liu, Thomas Ullrich, Kenner C. Rice, & Kathryn A. Cunningham. (2004). Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology. 178(4). 505–513. 56 indexed citations

13.

Bishop, Christopher, et al.. (2004). Serotonin 5-HT2A Receptors Underlie Increased Motor Behaviors Induced in Dopamine-Depleted Rats by Intrastriatal 5-HT2A/2C Agonism. Journal of Pharmacology and Experimental Therapeutics. 310(2). 687–694. 44 indexed citations

14.

Ullrich, Thomas, Karl Baumann, Karl Welzenbach, et al.. (2004). Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain. Bioorganic & Medicinal Chemistry Letters. 14(10). 2483–2487. 18 indexed citations

15.

Fantegrossi, William E., et al.. (2003). Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology. 166(3). 202–211. 98 indexed citations

16.

Kim, In Jong, Thomas Ullrich, James W. Janetka, et al.. (2003). Diaryldimethylpiperazine ligands with μ- and δ-opioid receptor affinity: Synthesis of (+)-4-[(αR)-α-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (−)-4-[(αR)-α-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide. Bioorganic & Medicinal Chemistry. 11(22). 4761–4768. 5 indexed citations

17.

Ullrich, Thomas, et al.. (2001). Enantioselective high‐performance liquid chromatography of therapeutically relevant aminoalcohols as their fluorescent 1‐naphthyl isocyanate derivatives. Biomedical Chromatography. 15(3). 212–216. 10 indexed citations

18.

Ullrich, Thomas, et al.. (2001). Derivatives of 17-(2-methylallyl)-substituted noroxymorphone: variation of the delta address and its effects on affinity and selectivity for the delta opioid receptor. Bioorganic & Medicinal Chemistry Letters. 11(21). 2883–2885. 7 indexed citations

19.

Ullrich, Thomas & Kenner C. Rice. (2000). A practical synthesis of the serotonin 5-HT2a receptor antagonist mdl 100907, its enantiomer and their 3-phenolic derivatives as precursors for [11c]labeled pet ligands. Bioorganic & Medicinal Chemistry. 8(10). 2427–2432. 35 indexed citations

20.

Ullrich, Thomas, Stefanie Oberle, Aida Abate, & H. Schröder. (1997). Photoactivation of the nitric oxide donor SIN‐1. FEBS Letters. 406(1-2). 66–68. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact